Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2006
04/04/2006CA2294624C Cationic monobenzene nitrophenylenediamines, their use in dying keratin fibres, dyeing compositions containing them and dyeing processes
04/04/2006CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
04/04/2006CA2241787C Substituted aza- and diazacycloheptane and cyclooctane compounds and their use
04/04/2006CA2166315C Process for the preparation of thalidomide
04/04/2006CA2043976C Substituted phthalides and heterocyclic phthalides
03/2006
03/30/2006WO2006034333A2 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
03/30/2006WO2006034277A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
03/30/2006WO2006034004A2 Processes and intermediates for preparing cysteine protease inhibitors
03/30/2006WO2006033446A1 Aminoalcohol derivatives
03/30/2006WO2006033011A1 Novel processes for the production of useful intermediates
03/30/2006WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
03/30/2006WO2005117867A3 Monocyclic heterocycles as kinase inhibitors
03/30/2006US20060069265 Reacting cysteine (or a salt or an ester) and an aryl carboxylic acid to form a thiazoline ring; stereospecifically alkylating the thiazoline ring, and hydrolyzing the thiazoline ring to obtain a 2-alkylcysteine; chelation
03/30/2006US20060069261 Useful for the manufacture of a medicament for treating HIV infection in a human infected by HIV. The compounds are potent inhibitors of wild-type (WT) and double mutant strains of HIV-1 RT, particularly the double mutant K103N/Y181C; benzophenone derivatives
03/30/2006US20060069260 Preparation of N-aryl pyridones
03/30/2006US20060069257 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
03/30/2006US20060069255 Novel aryl ureido benzoic acid derivatives and their use
03/30/2006US20060069111 Such as 2-exo-[5'-(3'-Amino-2'-fluoropyridinyl)]-7-azabicyclo[2.2.1]-heptane; Tourette's syndrome
03/30/2006US20060069084 Methods of inhibiting kinases
03/30/2006US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
03/30/2006DE102004046236A1 Arzneimittelzubereitung The pharmaceutical preparation
03/30/2006DE102004046235A1 Arzneimittelzubereitung The pharmaceutical preparation
03/30/2006CA2580760A1 Aminoalcohol derivatives
03/30/2006CA2580747A1 Novel processes for the production of useful intermediates
03/30/2006CA2580238A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
03/30/2006CA2580065A1 Processes and intermediates for preparing cysteine protease inhibitors
03/29/2006EP1640373A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
03/29/2006EP1640366A1 Heterocyclic methyl sulfone derivative
03/29/2006EP1640005A2 Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin B6
03/29/2006EP1638980A1 Process for preparing 3-aminothienopyridone derivatives
03/29/2006EP1638974A2 Triazolopyrimidines
03/29/2006EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
03/29/2006EP1638928A1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides
03/29/2006EP1638924A1 Pesticidally active ketone and oxime derivatives
03/29/2006EP1638923A2 Fungicidal phenoxyphenylhydrazine derivatives
03/29/2006EP1638505A2 Amphiphilic pyridinium compounds, method of making and use thereof
03/29/2006EP1638400A2 Triazolopyrimidines
03/29/2006EP1379234B1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf
03/29/2006EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor
03/29/2006EP0979823B1 Novel amide compounds and drugs containing the same
03/29/2006CN1753882A Ethynyl derivatives serving as factor XA inhibitors
03/29/2006CN1753873A Cyanopyridone derivatives as liquid crystals
03/29/2006CN1753872A Process for the production of substituted nicotinic acid esters
03/29/2006CN1753866A Arylcycloalkyl derivatives having branched side chains used as ppar receptor regulator, processes for their preparation and their use as pharmaceuticals
03/29/2006CN1753861A Novel aminobenzophenone compounds
03/29/2006CN1753673A Prodrugs of gaba analogs, compositions and uses thereof
03/29/2006CN1247585C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives
03/29/2006CN1247574C Isoindolin-1-one glucokinase activators
03/29/2006CN1247572C Method of producing nitroguanidine-and nitroenamine derivatives
03/29/2006CN1247570C Novel pyridyl cyanoguandine compounds
03/29/2006CN1247569C Novel pyrimidyl sulfamide compounds with anti-tumor activity and their salts
03/29/2006CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
03/29/2006CN1247544C Anthranilic acid amides with heteroarylsulfonyl side chain and use thereof as active substance for antiarythmia
03/29/2006CN1247529C Process for preparing N-aroyl-L-glutaminic acid
03/28/2006US7019156 Complex derivatives of bis(2-acetylpyridinethiosemicarbazonato-N1,N2,S)gallium(III) as anticarcinogenic agents
03/28/2006US7019138 cobalt metal complexed with a bi or tridentate bi or tripyridine ligands; useful as electron-transfer mediators in dye-sensitized solar cells and related photoelectrochromic devices
03/28/2006US7019137 Alkylation of 2,3-dihydro-1,4-benzodioxin-5-amine in chlorobenzene using trifluoromethanesulfonic acid salts of N,N-bis(2-chloroethyl)-alanine methyl ester, to form serotonin receptor antagonists; nervous system disorders
03/28/2006US7019033 For therapy of cancer and other proliferative diseases such as inflammation, psoriasis and restenosis, as well as stroke, heart failure, and immunodeficiency disorders
03/28/2006US7019030 Immunotherapeutic agents
03/28/2006US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
03/28/2006US7019006 Compounds useful as anti-inflammatory agents
03/28/2006US7019003 Bactericides
03/28/2006US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer
03/28/2006US7018949 Substituted pyridyl amine catalysts and processes for polymerizing and polymers
03/28/2006US7018851 chelate compounds joined to antibodies, antigens, receptor ligands, binding proteins and DNA or RNA probes, for use in bioassays
03/28/2006CA2386793C New selective retinoid agonists
03/28/2006CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
03/28/2006CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
03/23/2006WO2006030909A1 Process for production of 2-hydroxy-4-substituted pyridines
03/23/2006WO2006030807A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity
03/23/2006WO2006030211A2 Acyclic sulphonamides
03/23/2006WO2006030208A1 Amino acid
03/23/2006WO2006030032A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
03/23/2006WO2006029906A1 Methylene dipiperidine derivatives
03/23/2006WO2006029850A1 Hydrazone derivatives and their use as beta secretase inhibitors
03/23/2006WO2006008133A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
03/23/2006US20060063843 Compounds for the treatment of inflammatory disorders
03/23/2006US20060063820 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
03/23/2006US20060063797 Process for preparing a substituted imidazopyridine compound
03/23/2006US20060063783 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors
03/23/2006US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
03/23/2006US20060063760 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006US20060063741 Compounds useful as pesticides
03/23/2006DE112004000832T5 Lichtemittierende Polymerzusammensetzung Light-emitting polymer composition
03/23/2006CA2581144A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
03/23/2006CA2579799A1 Benzoyl-substituted serine amides
03/23/2006CA2579472A1 Hydrazone derivatives and their use as beta secretase inhibitors
03/22/2006EP1636205A1 Pyridinyl carbamates as hormone-sensitive lipase inhibitors
03/22/2006EP1636189A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
03/22/2006EP1636188A1 Para-substituted phenyl carbamates as inhibitors of hormone sensitive lipase
03/22/2006EP1636187A1 Substituted piperazine carbamates for use as inhibitors of hormone sensitive lipase
03/22/2006EP1636174A1 Inhibitors of matrix metalloproteinase
03/22/2006EP1636160A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
03/22/2006EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases
03/22/2006EP1635827A1 Pyridine n-oxides as antiviral agents
03/22/2006EP1539770B1 Preparation of metal amide complexes
03/22/2006EP1521820B1 Use of metal complex compounds as oxidation catalysts
03/22/2006EP1392652B1 Method for producing 1,3-disubstituted 2-nitroguanidines
03/22/2006EP1248618B1 Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl